Skip to main content
Top
Published in: Supportive Care in Cancer 3/2017

Open Access 01-03-2017 | Original Article

Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study

Authors: Martine T. E. Puts, Schroder Sattar, Kara McWatters, Katherine Lee, Michael Kulik, Mary-Ellen MacDonald, Raymond Jang, Eitan Amir, Monika K. Krzyzanowska, Natasha Leighl, Margaret Fitch, Anthony M. Joshua, Padraig Warde, Ann E. Tourangeau, Shabbir M. H. Alibhai

Published in: Supportive Care in Cancer | Issue 3/2017

Login to get access

Abstract

Purpose

Although comorbidities, frailty, and functional impairment are common in older adults (OA) with cancer, little is known about how these factors are considered during the treatment decision-making process by OAs, their families, and health care providers. Our aim was to better understand the treatment decision process from all these perspectives.

Methods

A mixed methods multi-perspective longitudinal study using semi-structured interviews and surveys with 29 OAs aged ≥70 years with advanced prostate, breast, colorectal, or lung cancer, 24 of their family members,13 oncologists, and 15 family physicians was conducted. The sample was stratified on age (70–79 and 80+). All interviews were analyzed using thematic analysis.

Results

There was no difference in the treatment decision-making experience based on age. Most OAs felt that they should have the final say in the treatment decision, but strongly valued their oncologists’ opinion. “Trust in my oncologist” and “chemotherapy as the last resort to prolong life” were the most important reasons to accept treatment. Families indicated a need to improve communication between them, the patient and the specialist, particularly around goals of treatment. Comorbidity and potential side-effects did not play a major role in the treatment decision-making for patients, families, or oncologists. Family physicians reported no involvement in decisions but desired to be more involved.

Conclusion

This first study using multiple perspectives showed neither frailty nor comorbidity played a role in the treatment decision-making process. Efforts to improve communication were identified as an opportunity that may enhance quality of care.

Condensed abstract

In a mixed methods study multiple perspective study with older adults with cancer, their family members, their oncologist and their family physician we explored the treatment decision making process and found that most older adults were satisfied with their decision. Comorbidity, functional status and frailty did not impact the older adult’s or their family members’ decision.
Appendix
Available only for authorised users
Literature
1.
go back to reference Santoni G, Angleman S, Welmer AK, Mangialasche F, Marengoni A, Fratiglioni L (2015) Age-related variation in health status after age 60. PLoS One 10(3):e0120077CrossRefPubMedPubMedCentral Santoni G, Angleman S, Welmer AK, Mangialasche F, Marengoni A, Fratiglioni L (2015) Age-related variation in health status after age 60. PLoS One 10(3):e0120077CrossRefPubMedPubMedCentral
2.
go back to reference Bergman H, Ferrucci L, Guralnik J et al (2007) Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci 62(7):731–737CrossRefPubMedPubMedCentral Bergman H, Ferrucci L, Guralnik J et al (2007) Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci 62(7):731–737CrossRefPubMedPubMedCentral
3.
go back to reference Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ (2012) Reasons for underuse of recommended therapies for colorectal and lung cancer in the veterans health administration. Cancer 118(13):3345–3355CrossRefPubMed Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ (2012) Reasons for underuse of recommended therapies for colorectal and lung cancer in the veterans health administration. Cancer 118(13):3345–3355CrossRefPubMed
4.
go back to reference Monroe MM, Myers JN, Kupferman ME (2013) Undertreatment of thick head and neck melanomas: an age-based analysis. Ann Surg Oncol 20(13):4362–4369CrossRefPubMed Monroe MM, Myers JN, Kupferman ME (2013) Undertreatment of thick head and neck melanomas: an age-based analysis. Ann Surg Oncol 20(13):4362–4369CrossRefPubMed
5.
go back to reference Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW (2013) Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 108(7):1534–1540CrossRefPubMedPubMedCentral Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW (2013) Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 108(7):1534–1540CrossRefPubMedPubMedCentral
6.
go back to reference Shumway DA, Hamstra DA (2015) Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence? J Clin Oncol 33(7):676–678CrossRefPubMed Shumway DA, Hamstra DA (2015) Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence? J Clin Oncol 33(7):676–678CrossRefPubMed
7.
go back to reference Weiss A, Noorbaksh A, Tokin C, Chang D, Blair SL (2013) Hormone receptor-negative breast cancer: undertreatment of patients over 80. Ann Surg Oncol 20(10):3274–3278CrossRefPubMed Weiss A, Noorbaksh A, Tokin C, Chang D, Blair SL (2013) Hormone receptor-negative breast cancer: undertreatment of patients over 80. Ann Surg Oncol 20(10):3274–3278CrossRefPubMed
8.
go back to reference Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29(1):106–117CrossRefPubMed Lee L, Cheung WY, Atkinson E, Krzyzanowska MK (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29(1):106–117CrossRefPubMed
9.
go back to reference Hurria A, Naeim A, Elkin E et al (2007) Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol 61(3):255–260CrossRefPubMed Hurria A, Naeim A, Elkin E et al (2007) Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol 61(3):255–260CrossRefPubMed
10.
go back to reference Wan-Chow-Wah D, Monette J, Monette M et al (2011) Difficulties in decision making regarding chemotherapy for older cancer patients: a census of cancer physicians. Crit Rev Oncol Hematol 78(1):45–58CrossRefPubMed Wan-Chow-Wah D, Monette J, Monette M et al (2011) Difficulties in decision making regarding chemotherapy for older cancer patients: a census of cancer physicians. Crit Rev Oncol Hematol 78(1):45–58CrossRefPubMed
11.
go back to reference Puts MT, Girre V, Monette J et al (2010) Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: a qualitative study. Crit Rev Oncol Hematol 74(2):87–96CrossRefPubMed Puts MT, Girre V, Monette J et al (2010) Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: a qualitative study. Crit Rev Oncol Hematol 74(2):87–96CrossRefPubMed
12.
go back to reference Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC (2009) Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg 208(2):202–209CrossRefPubMed Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC (2009) Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg 208(2):202–209CrossRefPubMed
13.
go back to reference Puts MT, Tapscott B, Fitch M et al (2015) A systematic review of factors influencing older adults' decision to accept or decline cancer treatment. Cancer Treat Rev 41(2):197–215CrossRefPubMed Puts MT, Tapscott B, Fitch M et al (2015) A systematic review of factors influencing older adults' decision to accept or decline cancer treatment. Cancer Treat Rev 41(2):197–215CrossRefPubMed
14.
go back to reference Lifford KJ, Witt J, Burton M et al (2015) Understanding older women's decision making and coping in the context of breast cancer treatment. BMC Med Inform Decis Mak 15:45CrossRefPubMedPubMedCentral Lifford KJ, Witt J, Burton M et al (2015) Understanding older women's decision making and coping in the context of breast cancer treatment. BMC Med Inform Decis Mak 15:45CrossRefPubMedPubMedCentral
15.
go back to reference Morgan JL, Burton M, Collins K et al (2015) The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer. Psychooncology 24(12):1761–1766CrossRefPubMed Morgan JL, Burton M, Collins K et al (2015) The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer. Psychooncology 24(12):1761–1766CrossRefPubMed
16.
go back to reference Wildiers H, Heeren P, Puts M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32(24):2595–2603CrossRefPubMedPubMedCentral Wildiers H, Heeren P, Puts M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32(24):2595–2603CrossRefPubMedPubMedCentral
17.
go back to reference Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM (2012) Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 104(15):1134–1164CrossRefPubMedCentral Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM (2012) Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 104(15):1134–1164CrossRefPubMedCentral
18.
go back to reference Puts MT, Santos B, Hardt J et al (2014) An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 25(2):307–315CrossRefPubMed Puts MT, Santos B, Hardt J et al (2014) An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 25(2):307–315CrossRefPubMed
19.
go back to reference Kendall M, Murray SA, Carduff E et al (2009) Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs. BMJ 339:b4122CrossRefPubMed Kendall M, Murray SA, Carduff E et al (2009) Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs. BMJ 339:b4122CrossRefPubMed
20.
go back to reference Murray SA, Kendall M, Carduff E et al (2009) Use of serial qualitative interviews to understand patients' evolving experiences and needs. BMJ 339:b3702CrossRefPubMed Murray SA, Kendall M, Carduff E et al (2009) Use of serial qualitative interviews to understand patients' evolving experiences and needs. BMJ 339:b3702CrossRefPubMed
21.
go back to reference Creswell JW, Plano Clarke VL (2010) Designing and conducting mixed methods research, 2nd edn. Sage Publications, Thousand Oaks Creswell JW, Plano Clarke VL (2010) Designing and conducting mixed methods research, 2nd edn. Sage Publications, Thousand Oaks
22.
go back to reference Eisikovits Z, Koren C (2010) Approaches to and outcomes of dyadic interview analysis. Qual Health Res 20(12):1642–1655CrossRefPubMed Eisikovits Z, Koren C (2010) Approaches to and outcomes of dyadic interview analysis. Qual Health Res 20(12):1642–1655CrossRefPubMed
23.
go back to reference Patton MQ (1990) Qualitative evaluation and research methods. Sage Publications, Newbury Park CA Patton MQ (1990) Qualitative evaluation and research methods. Sage Publications, Newbury Park CA
24.
go back to reference Saliba D, Elliott M, Rubenstein LZ et al (2001) The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49(12):1691–1699CrossRefPubMed Saliba D, Elliott M, Rubenstein LZ et al (2001) The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49(12):1691–1699CrossRefPubMed
25.
go back to reference Degner LF, Sloan JA, Venkatesh P (1997) The control preferences scale. Can J Nurs Res 29(3):21–43PubMed Degner LF, Sloan JA, Venkatesh P (1997) The control preferences scale. Can J Nurs Res 29(3):21–43PubMed
26.
go back to reference Holmes-Rovner M, Kroll J, Schmitt N et al (1996) Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Mak 16(1):58–64CrossRef Holmes-Rovner M, Kroll J, Schmitt N et al (1996) Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Mak 16(1):58–64CrossRef
27.
go back to reference Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5(6):649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5(6):649–655CrossRefPubMed
29.
go back to reference Carstensen LL, Isaacowitz DM, Charles ST (1999) Taking time seriously. A theory of socioemotional selectivity. Am Psychol 54(3):165–181CrossRefPubMed Carstensen LL, Isaacowitz DM, Charles ST (1999) Taking time seriously. A theory of socioemotional selectivity. Am Psychol 54(3):165–181CrossRefPubMed
30.
go back to reference Hurria A, Wildes T, Baumgartner J, et al. (2015) Older Adult Oncology. National Comprehensive Cancer Network Hurria A, Wildes T, Baumgartner J, et al. (2015) Older Adult Oncology. National Comprehensive Cancer Network
31.
go back to reference Balducci L, Colloca G, Cesari M, Gambassi G (2010) Assessment and treatment of elderly patients with cancer. Surg Oncol 19(3):117–123CrossRefPubMed Balducci L, Colloca G, Cesari M, Gambassi G (2010) Assessment and treatment of elderly patients with cancer. Surg Oncol 19(3):117–123CrossRefPubMed
32.
go back to reference Extermann M (2011) Basic assessment of the older cancer patient. Curr Treat Options in Oncol 12(3):276–285CrossRef Extermann M (2011) Basic assessment of the older cancer patient. Curr Treat Options in Oncol 12(3):276–285CrossRef
33.
go back to reference Pallis AG, Fortpied C, Wedding U et al (2010) EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 46(9):1502–1513CrossRefPubMed Pallis AG, Fortpied C, Wedding U et al (2010) EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 46(9):1502–1513CrossRefPubMed
34.
go back to reference Wedding U, Kodding D, Pientka L, Steinmetz HT, Schmitz S (2007) Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 64(1):1–9CrossRefPubMed Wedding U, Kodding D, Pientka L, Steinmetz HT, Schmitz S (2007) Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 64(1):1–9CrossRefPubMed
35.
go back to reference Sada YH, Street RL Jr, Singh H, Shada RE, Naik AD (2011) Primary care and communication in shared cancer care: a qualitative study. Am J Manag Care 17(4):259–265PubMedPubMedCentral Sada YH, Street RL Jr, Singh H, Shada RE, Naik AD (2011) Primary care and communication in shared cancer care: a qualitative study. Am J Manag Care 17(4):259–265PubMedPubMedCentral
36.
go back to reference Nekhlyudov L, Latosinsky S (2010) The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr 2010(40):11–17CrossRefPubMedPubMedCentral Nekhlyudov L, Latosinsky S (2010) The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr 2010(40):11–17CrossRefPubMedPubMedCentral
Metadata
Title
Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
Authors
Martine T. E. Puts
Schroder Sattar
Kara McWatters
Katherine Lee
Michael Kulik
Mary-Ellen MacDonald
Raymond Jang
Eitan Amir
Monika K. Krzyzanowska
Natasha Leighl
Margaret Fitch
Anthony M. Joshua
Padraig Warde
Ann E. Tourangeau
Shabbir M. H. Alibhai
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3476-8

Other articles of this Issue 3/2017

Supportive Care in Cancer 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine